SCHEMBL101404

SCHEMBL101404

CC(C)CCCC(C)CCOCC(O)COCCC(C)CCCC(C)C

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
HSD17B10 Q99714 1/20 0.43
BLM P54132 1/20 0.42
PTPN1 P18031 2/20 0.38
CYP3A4 P08684 2/20 0.38
MEN1 O00255 1/20 0.38
ALOX15 P16050 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
USP2 O75604 1/20 0.36
HTT P42858 1/20 0.35
LPAR5 Q9H1C0 1/20 0.34
SPHK1 Q9NYA1 1/20 0.33
FDPS P14324 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14893973 0.91 USP2 (0.46) LMNAHSD17B10BLMPTPN1CYP3A4
SCHEMBL10961284 0.91 USP2 (0.49) LMNAHSD17B10BLMPTPN1CYP3A4
SCHEMBL16670352 0.91 USP2 (0.49) LMNAHSD17B10BLMPTPN1CYP3A4
SCHEMBL3574123 0.91 USP2 (0.49) LMNAHSD17B10BLMPTPN1CYP3A4
SCHEMBL10556554 0.90 LMNA (0.41) LMNAHSD17B10BLMPTPN1CYP3A4
SCHEMBL10339685 0.89 HTT (0.50) LMNAHSD17B10BLMPTPN1CYP3A4
SCHEMBL10763001 0.88 USP2 (0.56) LMNAHSD17B10CYP3A4TDP1USP2
SCHEMBL27867301 0.88 HSD17B10 (0.54) LMNAHSD17B10BLMPTPN1CYP3A4
SCHEMBL28220210 0.85 LMNA (0.56) LMNAHSD17B10BLMPTPN1CYP3A4
Hydrochloric Acid SCHEMBL10554017 0.84 LMNA (0.36) LMNAHSD17B10BLMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426099-A1 Coalescent for aqueous compositions Rohm and Haas Company (US) 2012-03-07 EP disclosed
US-20120052210-A1 COALESCENT FOR AQUEOUS COMPOSITIONS VAN DYK ANTONY KEITH (US) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120052210-A1 COALESCENT FOR AQUEOUS COMPOSITIONS DGAT2, DGAT1, DAGLB LMNA 1055/4885HSD17B10 143/4885BLM 3584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.